Brookstone Capital Management’s Precigen PGEN Stock Holding History

Brookstone Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-48,593	Closed	-$242K	–	461
2020 Q2	$242K	Buy	+48,593	New	+$165K	0.02%	312

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Brookstone Capital Management's PGEN Position: Q3 2020 in Review

Brookstone Capital Management sold out of Precigen (PGEN) in Q3 2020, closing a stake of 48,593 shares — an estimated $242K sold.

Brookstone Capital Management first reported a position in PGEN in Q2 2020 and held it in 1 quarter. The position peaked at $242K in Q2 2020. 159 funds tracked by Wall St. Rank hold PGEN as of Q3 2020.

Brookstone Capital Management reported no remaining Precigen position as of Q3 2020 after selling out during the quarter.
Brookstone Capital Management sold 48,593 Precigen shares in Q3 2020, an estimated $242K.
Brookstone Capital Management first reported a position in Precigen in Q2 2020 and held it in 1 quarter.
Brookstone Capital Management's Precigen position peaked at $242K in Q2 2020.
159 funds tracked by Wall St. Rank held Precigen as of Q3 2020.

Based on Brookstone Capital Management's 13F filing for Q3 2020, filed 13 Oct 2020.